TGFB1 and neoplasm: Since the combination of ICI and TGF-β blocking antibodies has been shown to reduce TGF-β signaling and induce anti-tumor immunity, tumor regression in many preclinical models15,28–31, this combination therapy might be effective in preventing HPD.